Saint Luke's Cancer Institute - Nampa is a clinical research site located in Nampa, Idaho, United States 83687.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
Saint Luke's Cancer Institute - Nampa has participated in 232 clinical trials with 186 currently active.
Therapeutic areas: B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.
Sponsors: Children's Oncology Group, GOG Foundation, National Cancer Institute (NCI).
Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Saint Luke's Cancer Institute - Nampa has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Saint Luke's Cancer Institute - Nampa has 232 clinical trials on record, with 186 currently active. Their work covers B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, BCR-ABL1-Like.
Saint Luke's Cancer Institute - Nampa has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.